It is a once-daily tablet taken on an empty stomach, prescribed only after clinical assessment against BMI-based eligibility and used alongside a reduced-calorie diet and increased physical activity
The length and gauge of the needle may vary depending on the patients muscle mass and the injection site
Nearly 9% of the patients taking semaglutide had NAION, compared to only 1.8% of patients who were not taking semaglutide
1999 Oct;4(5):330-41
[DOI] [PubMed] [Google Scholar] 94.Badve S.V., Bilal A., Lee M.M.Y., Sattar N., Gerstein H.C., Ruff C.T., McMurray J.J.V., Rossing P., Bakris G., Mahaffey K.W., et al
Values above 3 ULN with symptoms, or above 5 ULN at any time, are the thresholds at which the monitoring protocol calls for pausing the drug